InsidersTradesSigma
Total declarations
Companies
▲ Purchases (4 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
4
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-21.6%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the complete record of transactions filed by Douglas Richard, Director. Director active across 3 companies, notably NOVAVAX INC. Aggregated, 14 filings have been logged. Split: 4 buys · 0 sell. Total volume traded: €696k. History available since 22 November 2021. The latest transaction was filed on 19 March 2026 (Acquisition). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Douglas Richard
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations14 total
18,880 sharesCommon StockSEC:0001104659-26-076927:0
30,421 sharesCommon StockSEC:0000905148-26-003053:0
70,000 shares@ US$1.40100.0% of flowCommon StockSEC:0001193125-26-117675:0
Canonical exit: 17 Jun 2026 (T+90)
80,000 shares@ US$1.38815.5% of flowCommon StockSEC:0000905148-25-002874:0
Canonical exit: 11 Nov 2025 (T+90)
29,210 shares0Common StockSEC:0000905148-25-002232:0
10,420 shares0Common StockSEC:0001593968-25-000757:0
6,670 shares0Common StockSEC:0001593968-24-000863:0
21,367 shares0Common StockSEC:0001415889-24-016715:0
3,100 sharesCommon StockSEC:0001209191-23-036744:0
80,000 shares@ US$4.318544.7% of flowCommon StockSEC:0001209191-23-021573:0
Canonical exit: 27 Jun 2023 (T+90)
700 sharesCommon StockSEC:0001209191-22-038592:0
1,500 shares@ US$25.60100.0% of flowCommon StockSEC:0001209191-21-069798:0
20,000 shares@ US$11.1232.3% of flowCommon StockSEC:0001209191-21-066289:0
Canonical exit: 20 Feb 2022 (T+90)
3,450 sharesCommon StockSEC:0001209191-21-043700:0
14 of 14 declarations
About Douglas Richard
DOUGLAS RICHARD is Administrateur at NOVAVAX INC, Maxcyte, INC. and Aldeyra Therapeutics, Inc. He has 14 filings in total, and across the recent sampled filings held, purchases amount to EUR 696122 and sales to EUR 0, over the period from 2021-06-29 to 2026-06-23. The modal transaction nature is Levée d'options.
